Discover more about rheumatoid factor (RF) and RA

Learn How a Biologic Like CIMZIA^® May Work For You

For rheumatoid arthritis

Patients taking CIMZIA (certolizumab pegol) as part of a clinical trial experienced these results.

Rapid Results

Nearly 6 out of 10 people on CIMZIA experienced joint pain relief and reduction in swollen and tender joints at 24 weeks—some in as fast as 1-2 weeks.*†

^†59% of CIMZIA patients at 24 weeks vs. 14% of placebo patients.

Improved Everyday Activities

People on CIMZIA reported significant improvement in daily activities at 6 months that made them more independent—like showering, getting dressed, doing chores, walking short distances, and running simple errands.*

Proven Against Further Joint Damage

Nearly 7 out of 10 people on CIMZIA were shown to have no further progression of joint damage, as shown by x-rays, at 1 year.‡

^‡69% of CIMZIA patients taking 200 mg every other week at 1 year vs. 52% of placebo patients.

*Results shown above are based on the recommended starting and maintenance doses of CIMZIA.
Results may vary; every person taking CIMZIA is different and responds differently to therapy.

New to Biologic Injections?

We want you to feel confident in your decision to start a new treatment.

Hear from real patients about their experience with CIMZIA, learn more about what to expect from treating your rheumatoid arthritis (RA) at home, or get familiar with how to self-administer CIMZIA.

In the following section, you can learn more about biologics and how CIMZIA works to treat your RA.

Been on a Biologic Before?

Ask your rheumatologist about switching to a biologic medication like CIMZIA and if it could make a difference—even if you've tried other biologics before. Talk to your doctor about how a biologic may work for you.

Proven Results Even With Prior
Biologic Use

5 out of 10^§ people taking CIMZIA saw improvement in signs and symptoms of rheumatoid arthritis at Week 12, even if they had previously been on another anti-TNF therapy.^||

^§51% of CIMZIA patients at 12 weeks vs 26% of placebo patients.
^||47% of CIMZIA patients at 12 weeks vs 28% of placebo patients.

Results may vary; every person taking CIMZIA is different and responds differently to therapy.

The Logic of a Biologic Medication Like CIMZIA

CIMZIA is a biologic. A biologic is a drug that comes from living sources. As an anti-tumor necrosis factor (TNF) biologic, CIMZIA works to block the extra TNF that leads to inflammatory pain.